MDSLD & Met-ALD

Sudden Cardiac Death

October 1, 2026

Published by mesn on October 5, 2026

Categories

FEATURED MEDICAL EDUCATION TOPIC: Breast Cancer

What is the problem?

About 1 in 8 U.S. women (about 13%) will develop invasive breast cancer throughout their lifetime. In 2026, an estimated 321,910 new invasive breast cancer diagnoses are expected in women in the U.S., along with 60,730 cases of ductal carcinoma in situ (DCIS) and 2,670 invasive cases in men. An estimated 42,140 women and 530 men will die of the disease in 2026. For women in the U.S., breast cancer death rates are higher than those for other cancers besides lung cancer. In 2021, according to the World Health Organization, breast cancer became the most common cancer globally. Physicians should understand the latest guidelines and treatment options to answer patients’ questions and coordinate care with specialists effectively.

Proposed Learning Objectives

Upon completion of this activity, participants will be able to:

Assess modifiable and non-modifiable breast cancer risk factors, including hormone replacement therapy, germline genetic mutations, reproductive history, and breast density
Describe the pathophysiology and epidemiology of breast cancer, including molecular subtypes
Identify prognostic and predictive indicators that inform treatment selection
Follow AJCC clinical and pathologic TNM staging guidelines and choose appropriate evidence-based treatment and management (surgical and nonsurgical) options
Summarize current and future research studies and clinical trials

If your medical staff needs an update on breast cancer, consider contacting our office to book a speaker at 714-505-4777 or info@speakersnetwork.com.